SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back

: Emerging Challenges in Primary Care 2017 San Diego, CA
Activity/Course #:
: 10.28.17PC

: Free
Release/Start Date:
: Oct 28 2017
Expiration Date:
: Oct 28 2017
: Primary Care Medicine
Target Audience:
: Primary Care Providers
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 7.0 hours
: 7.0 AMA PRA Category I Credit(s)
7.0 AANP Contact hour(s) which includes 3.5 pharmacology hour(s)
Hardware/Software Requirements:

Saturday, October 28, 2017

Marriott San Diego La Jolla
4240 La Jolla Village Drive
La Jolla, CA 92037
(858) 587-1414

Registration Fee
There is no registration fee for this activity.

Special Accommodations

NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking

A discounted self-parking rate of $12.00 is available at the hotel.

Hotel Guest Rooms

NACE has reserved a sleeping room rate of $129 per night at the Marriott San Diego La Jolla. To reserve your room at this rate call (858) 587-1414 and ask for the NACE room block by September 26, 2017.  

Program Summary

Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.

Learning Objectives

At the conclusion of this program, participants should be able to:

1. Describe the role of the kidney in glucose metabolism in health and disease; Review the physiologic effects and clinical efficacy of SGLT-2 therapy in various patient populations; Review emerging data on possible renal and macrovascular effects of evidence-based diabetes treatment options; Integrate the impact of treatment decisions on postprandial hyperglycemia and risk of hypoglycemia.

2. Discuss the role of postprandial hyperglycemia in the pathogenesis of diabetic complications; Incorporate GLP-1 RA therapy into practice to reduce post-prandial hyperglycemia and decrease glycemic variability; Compare GLP-1 RAs for glycemic efficacy and differential impact on postprandial glycemic control; Discuss various GLP-1 RA combination strategies with or as a possible alternative to basal insulin in the diabetic patient not at glycemic target.

3. Describe strategies of care in COPD to improve diagnosis and ongoing symptom assessment; Tailor COPD pharmacotherapy according to current guidelines while incorporating unique patient needs and characteristics; Discuss the appropriate use of inhaled therapies for COPD, including the importance of proper inhaler technique; Collaborate with members of interprofessional health care team for effective chronic disease management.

4. Review the epidemiology and impact of pseudobulbar affect (PBA); Recognize the importance of early recognition of PBA in primary care; Describe diagnostic tools and criteria for objective diagnosis of PBA; Discuss therapeutic options for PBA.

5. Describe the role of persistent oncogenic HPV in the development of pre-cancer and cancer of the cervix; Describe the use of HPV testing as co-testing along with the Pap in cervical cancer screening for women 30 and older; Describe the use of HPV primary screening in women 25 and older; Describe 3 important messages that clinicians will teach women regarding HPV infection.

6. Discuss the diagnosis of osteoporosis and low bone mass; Discuss the role of non-pharmacologic agents in the prevention of bone fracture; Discuss the pharmacologic treatment of low bone mass and osteoporosis; Discuss the current controversies in management of osteoporosis.



7:30-8:00   Continental Breakfast and Registration
8:00-8:10   Welcome Remarks
Gregg Sherman, MD

Integrating Data on Macrovascular and Microvascular Outcomes into Diabetes Management: Evolving Treatment Strategies
Richard S. Beaser, MD


GLP-1 Receptor Agonists: New Insights and New Strategies for Successful Long-Term Diabetes Management
Richard S. Beaser, MD

10:30-10:50   Break
10:50-12:00   The Evolving Landscape of COPD: Strategies to Optimize Care and Improve Outcomes
Arunabh Talwar, MD, FCCP

Presentation Theater: A Patient-Centered Approach to Help Awaken a Transformation for Adults With T2DM
(CME not offered)

1:10-2:20   Pseudobulbar Affect: A Call to Action
Gustavo Alva, MD, DFAPA

Cervical Cancer Screening: Appropriate Use of Pap & HPV Testing
Nancy R. Berman, MSN, ANP-BC, NCMP, FAANP

 3:30-3:40 Break
 3:40-4:50 Osteoporosis and Fracture Prevention Strategies
Nancy R. Berman, MSN, ANP-BC, NCMP, FAANP

Program Summary and Closing Remarks
Gregg Sherman, MD

 *Agenda subject to change.


Gustavo Alva, MD, DFAPA
Medical Director, ATP Clinical Research
Volunteer Faculty (Assistant Clinical Professor),
Department of Psychiatry
University of California
Riverside, CA

Richard S. Beaser, MD
Senior Staff Physician,
Medical Director of Professional Education
Joslin Diabetes Center
Associate Clinical Professor of Medicine
Harvard Medical School
Boston, MA

Nancy R. Berman, MSN, ANP-BC, NCMP, FAANP
Adult Nurse Practitioner
Certified Menopause Practitioner
Millennium Affiliated Physicians
Division of Michigan Healthcare Professionals
Farmington Hills, MI

Arunabh Talwar, MD, FCCP
Director, Pulmonary Hypertension and Advanced Lung Disease Program
North Shore University Hospital, Manhasset, New York
Professor Of Medicine
Hofstra Northwell School of Medicine
Hofstra University
Hempstead, NY

Planning Committee

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL

Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education
Plantation, FL

Michelle Frisch, MPH, CHCP
National Association for Continuing Education
Plantation, FL

Cassandra A. McCullough, MBA
Chief Executive Officer
Association of Black Cardiologists
New York, NY

Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education
Plantation, FL

Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 7 contact hours of continuing education (which includes 3.5 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
Emerging Challenges in Primary Care: 2017 is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.; and an independent medical educational grant from Sunovion Pharmaceuticals, Inc.